LABORATORY CORPORATION OF AMERICA HOLDINGS

Laboratory Corporation of America Holdings

LH

US50540R4092

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
198.4 ^USD	-4.61%		-0.55%	-12.73%

10:14pm	Evercore ISI Cuts Laboratory Corp of America Holdings' Price Target to $210 From $225	MT
07:00pm	Leerink Partners Adjusts Laboratory Corp of America Price Target to $242 From $260, Keeps Outperform Rating	MT

LABORATORY CORP OF AMERICA HOLDINGS : Financial Statements and Exhibits (form 8-K)

January 06, 2020 at 08:07 am EST

Item 9.01 Financial Statements and Exhibits.



Exhibit      Exhibit Name
Exhibit 99.1   Press Release dated January 6, 2020, issued by LabCorp

--------------------------------------------------------------------------------

Latest news about Laboratory Corporation of America Holdings

Evercore ISI Cuts Laboratory Corp of America Holdings' Price Target to $210 From $225	04:14pm	MT
Leerink Partners Adjusts Laboratory Corp of America Price Target to $242 From $260, Keeps Outperform Rating	01:00pm	MT
Laboratory Corp of America Q1 Adjusted Earnings, Revenue Increase; 2024 Adjusted EPS Outlook Updated	09:28am	MT
Transcript : Laboratory Corporation of America Holdings, Q1 2024 Earnings Call, Apr 25, 2024	09:00am
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 Revenue $3.18B, vs. Street Est of $3.12B	07:34am	MT
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 EPS $3.68, vs. Street Est of $3.48	07:33am	MT
Laboratory Corporation of America Holdings Reports Earnings Results for the First Quarter Ended March 31, 2024	07:05am	CI
Labcorp beats quarterly estimates on strong testing demand	06:59am	RE
North American Morning Briefing : More Tech -2-	06:07am	DJ
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	10:23pm	RE
Laboratory Corporation of America Holdings Announces Winning Bid for Select Assets of Invitae	09:27pm	CI
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million.	Apr. 23	CI
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation for approximately $240 million.	Apr. 23	CI
Labcorp Introduces Test for Early Detection of Neurodegenerative Diseases	Apr. 15	MT
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw	Apr. 15	CI
Labcorp Keeps Quarterly Dividend at $0.72 Per Share, Payable June 12 to Stockholders of Record May 28	Apr. 11	MT
Labcorp Declares Quarterly Dividend, Payable on June 12, 2024	Apr. 11	CI
Sector Update: Health Care Stocks Slump Wednesday Afternoon	Apr. 10	MT
Labcorp Says US FDA Granted Emergency Use Authorization for Mpox Home Collection Kit	Apr. 10	MT
Labcorp Gets Emergency Authorization from FDA for Home Kit to Detect Monkeypox	Apr. 10	DJ
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit	Apr. 10	CI
Laboratory Corp of America Expands Precision Oncology Portfolio	Apr. 08	MT
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs	Apr. 08	CI
Labcorp Launches Labcorp Plasma Detect? Extending Leadership into Molecular Residual Disease Clinical Research	Apr. 05	CI
Laboratory Corporation Receives a Shareholder Proposal from People for the Ethical Treatment of Animals	Apr. 04	CI

Chart Laboratory Corporation of America Holdings

Duration

Period

Chart Laboratory Corporation of America Holdings

More charts

Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).

Sector

Healthcare Facilities & Services

Calendar

2024-04-24 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Laboratory Corporation of America Holdings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

207.9 USD

Average target price

243.8 USD

Spread / Average Target

+17.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.73%	17.49B
CVS HEALTH CORPORATION	-14.73%	85.42B
HCA HEALTHCARE, INC.	+16.05%	84.38B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.39B
FRESENIUS SE & CO. KGAA	-3.17%	16.44B
QUEST DIAGNOSTICS INCORPORATED	-1.78%	15.28B
FRESENIUS MEDICAL CARE AG	-0.45%	12.22B
PURE HEALTH HOLDING	-31.23%	11.98B
EUROFINS SCIENTIFIC SE	-2.51%	11.71B
DAVITA INC.	+26.74%	11.64B

Other Healthcare Facilities & Services

Laboratory Corporation of America Holdings

Equities

LH

US50540R4092

Healthcare Facilities & Services

LABORATORY CORP OF AMERICA HOLDINGS : Financial Statements and Exhibits (form 8-K)

Latest news about Laboratory Corporation of America Holdings

Chart Laboratory Corporation of America Holdings

Company Profile

Income Statement Evolution

Ratings for Laboratory Corporation of America Holdings

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Healthcare Facilities & Services